Viral Hepatitis
Copyright ©The Author(s) 2004.
World J Gastroenterol. Apr 1, 2004; 10(7): 972-976
Published online Apr 1, 2004. doi: 10.3748/wjg.v10.i7.972
Table 3 Sequential changes and comparisons of serum ferritin levels (μg/L) at different time points during lamivudine treatment in HBeAb-negative and -positive groups at end of treatment
GroupBaselineMonths after treatment
3612
HBV DNA ( - ) group (n = 10)249.19 ± 176.48147.33 ± 147.60114.47 ± 76.62104.41 ± 78.60
HBV DNA ( + ) group (n = 28)195.07 ± 137.31159.74 ± 96.94129.85 ± 72.26134.61 ± 87.51
P values0.3280.7650.5770.346